Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Simulations Plus, Inc.

Market Cap 330M 285M 262M 246M 460M 31.34B 468M 3.1B 1.21B 15.26B 1.24B 1.21B 52.82B P/E Ratio 2026 *
39.1x
P/E Ratio 2027 * 36.1x
Enterprise Value 330M 285M 262M 246M 460M 31.34B 468M 3.1B 1.21B 15.26B 1.24B 1.21B 52.82B EV / Sales 2026 *
4.03x
EV / Sales 2027 * 3.81x
Free-Float
82.79%
Yield 2026 *
-
Yield 2027 * -
1 day-1.03%
1 week+2.77%
Current month-4.62%
1 month+20.27%
3 months+31.19%
6 months-14.87%
Current year-10.48%
1 week 15.64
Extreme 15.64
16.82
1 month 13.21
Extreme 13.21
17.76
Current year 11.09
Extreme 11.09
21.01
1 year 11.09
Extreme 11.09
21.01
3 years 11.09
Extreme 11.09
52.69
5 years 11.09
Extreme 11.09
67.59
10 years 6.74
Extreme 6.74
90.92
Manager TitleAgeSince
Chief Executive Officer 67 26/06/2018
Director of Finance/CFO 63 01/12/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 81 17/07/1996
Director/Board Member 58 03/12/2014
Chairman 76 17/12/2024
Date Insider Type Main position Quantity % Market Cap.
06-03Sell

Executive/Senior Manager

-1,000 0.0050%
06-01Sell

Founder

-15,000 0.0745%
05-11Fiscal year

Executive/Senior Manager

3,000 0.0149%
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%+2.77%-14.42%-65.04% 330M
-1.24%-7.57%-43.54%-16.41% 25.92B
+0.74%-0.99%-39.37%+150.96% 12.08B
-0.07%+3.07%-3.76%+54.63% 6.19B
+8.38%+18.29% - - 2.87B
+0.03%-12.02%+29.33%-47.78% 1.72B
-4.25%-3.81% - - 1.59B
+2.32%-0.30%-30.41% - 1.29B
+0.57%-4.31%-33.27%-59.98% 813M
+3.19%+0.46%-28.16%+214.12% 803M
Average +0.86%-0.83%-20.45%+32.93% 5.36B
Weighted average by Cap. -0.01%-3.14%-33.99%+36.71%

Financials

2026 *2027 *
Net sales 81.75M 70.61M 65.07M 60.91M 114M 7.77B 116M 768M 300M 3.78B 307M 300M 13.1B 86.53M 74.74M 68.87M 64.47M 121M 8.22B 123M 813M 317M 4B 325M 318M 13.86B
Net income 9.02M 7.79M 7.18M 6.72M 12.6M 858M 12.79M 84.79M 33.06M 417M 33.86M 33.14M 1.45B 9.71M 8.39M 7.73M 7.23M 13.56M 923M 13.77M 91.25M 35.58M 449M 36.44M 35.66M 1.56B
Net Debt - -
Logo Simulations Plus, Inc.
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.
Employees
213
Date Price Change Volume
12/06/26 16.32 $ -1.03% 160,725
11/06/26 16.49 $ +3.45% 171,492
10/06/26 15.94 $ -0.44% 172,893
09/06/26 16.01 $ +0.63% 182,321
08/06/26 15.91 $ +0.19% 184,027
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
16.32USD
Average target price
23.50USD
Spread / Average Target
+44.00%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!